Payment overview · 2025
General Payments
$663.76
9 reported records · 4 companies
Healthcare provider profile · identity verified
Eric Cary Brooks, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology · WEST BLOOMFIELD, MI · NPI 1689707333
Verified facts
What the public records show
CMS Open Payments records show Eric Cary Brooks, M.D. received $663.76 in general payments during 2025 across 9 reported records.
Teva Pharmaceuticals USA, Inc. accounted for 40.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
E.R. Squibb & Sons, L.L.C. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 27956 records involving 14870 distinct recipient NPIs. Public Medicare Part D data also shows 1384 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $268.42 | 40.4% | 3 | 2025 |
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $227.06 | 34.2% | 4 | 2025 |
| E.R. Squibb & Sons, L.L.C. | Unresolved — no canonical attribution shown | $124.74 | 18.8% | 1 | 2025 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | Unresolved — no canonical attribution shown | $43.54 | 6.6% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $663.76 | 9 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $268.42 | 3 | 2025 |
Source payment records
|
|||||
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $227.06 | 4 | 2025 |
Source payment records
|
|||||
| COBENFY Normalized: cobenfy |
Drug | E.R. Squibb & Sons, L.L.C. | $124.74 | 1 | 2025 |
Source payment records
|
|||||
| DRIZALMA SPRINKLE Normalized: drizalma sprinkle |
Drug | SUN PHARMACEUTICAL INDUSTRIES INC. | $43.54 | 1 | 2025 |
Source payment records
|
|||||
| KAPSPARGO Normalized: kapspargo |
Drug | SUN PHARMACEUTICAL INDUSTRIES INC. | $43.54 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 27956 supporting records · 14870 recipient NPIs · example record 1184377713 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
1384 | 70 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 3416 | 212 |
| Amlodipine Besylate | Amlodipine Besylate | 2374 | 166 |
| Metoprolol Tartrate | Metoprolol Tartrate | 1712 | 124 |
| Divalproex Sodium | Divalproex Sodium | 1653 | 73 |
| Pantoprazole Sodium | Pantoprazole Sodium | 1604 | 84 |
| Eliquis | Apixaban | 1384 | 70 |
| Lisinopril | Lisinopril | 1330 | 82 |
| Quetiapine Fumarate | Quetiapine Fumarate | 1235 | 66 |
| Tamsulosin Hcl | Tamsulosin Hcl | 1000 | 62 |
| Trazodone Hcl | Trazodone Hcl | 955 | 61 |
| Furosemide | Furosemide | 881 | 55 |
| Levothyroxine Sodium | Levothyroxine Sodium | 814 | 52 |
| Risperidone | Risperidone | 750 | 52 |
| Hydralazine Hcl | Hydralazine Hcl | 744 | 48 |
| Famotidine | Famotidine | 668 | 45 |
| Levetiracetam | Levetiracetam | 663 | 36 |
| Metformin Hcl | Metformin Hcl | 663 | 50 |
| Olanzapine | Olanzapine | 620 | 38 |
| Omeprazole | Omeprazole | 615 | 62 |
| Potassium Chloride | Potassium Chloride | 575 | 48 |
| Haloperidol | Haloperidol | 563 | 24 |
| Losartan Potassium | Losartan Potassium | 560 | 59 |
| Sertraline Hcl | Sertraline Hcl | 528 | 37 |
| Carvedilol | Carvedilol | 489 | 36 |
| Metoprolol Succinate | Metoprolol Succinate | 457 | 51 |
| Januvia | Sitagliptin Phosphate | 424 | 32 |
| Mirtazapine | Mirtazapine | 377 | 41 |
| Donepezil Hcl | Donepezil Hcl | 373 | 22 |
| Gabapentin | Gabapentin | 346 | 42 |
| Clonidine Hcl | Clonidine Hcl | 345 | 28 |
| Escitalopram Oxalate | Escitalopram Oxalate | 319 | 30 |
| Jardiance | Empagliflozin | 313 | 18 |
| Aripiprazole | Aripiprazole | 311 | 19 |
| Clopidogrel | Clopidogrel Bisulfate | 293 | 26 |
| Duloxetine Hcl | Duloxetine Hcl | 293 | 22 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 258 | 30 |
| Tramadol Hcl | Tramadol Hcl | 254 | 53 |
| Clonazepam | Clonazepam | 244 | 41 |
| Topiramate | Topiramate | 241 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 235 | 26 |
| Benztropine Mesylate | Benztropine Mesylate | 221 | 23 |
| Simvastatin | Simvastatin | 213 | 19 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 200 | 41 |
| Finasteride | Finasteride | 195 | 11 |
| Midodrine Hcl | Midodrine Hcl | 188 | 24 |
| Oxybutynin Chloride | Oxybutynin Chloride | 187 | 18 |
| Pravastatin Sodium | Pravastatin Sodium | 184 | suppressed |
| Lorazepam | Lorazepam | 174 | 39 |
| Latanoprost | Latanoprost | 170 | 25 |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 162 | 25 |
| Nifedipine Er | Nifedipine | 162 | 17 |
| Fluoxetine Hcl | Fluoxetine Hcl | 155 | suppressed |
| Methocarbamol | Methocarbamol | 151 | 24 |
| Olanzapine Odt | Olanzapine | 149 | suppressed |
| Xarelto | Rivaroxaban | 148 | 14 |
| Hydrochlorothiazide | Hydrochlorothiazide | 146 | 18 |
| Fenofibrate | Fenofibrate Nanocrystallized | 145 | 13 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 143 | 32 |
| Fluticasone Propionate | Fluticasone Propionate | 142 | 31 |
| Memantine Hcl | Memantine Hcl | 140 | 11 |
| Ammonium Lactate | Ammonium Lactate | 137 | 23 |
| Montelukast Sodium | Montelukast Sodium | 137 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 135 | 18 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 134 | 20 |
| Diltiazem Hcl | Diltiazem Hcl | 132 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 132 | 28 |
| Paroxetine Hcl | Paroxetine Hcl | 130 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 127 | 33 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 127 | 11 |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 124 | 22 |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 119 | 22 |
| Citalopram Hbr | Citalopram Hydrobromide | 114 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 97 | 16 |
| Amiodarone Hcl | Amiodarone Hcl | 94 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 94 | suppressed |
| Fenofibrate | Fenofibrate | 93 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 92 | 20 |
| Digoxin | Digoxin | 91 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 89 | 20 |
| Lamotrigine | Lamotrigine | 88 | suppressed |
| Valproic Acid | Valproic Acid | 87 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 85 | 12 |
| Alcohol Swabs | Alcohol Antiseptic Pads | 84 | 15 |
| Paliperidone Er | Paliperidone | 84 | suppressed |
| Carbamazepine Er | Carbamazepine | 83 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 83 | 20 |
| Entresto | Sacubitril/Valsartan | 82 | suppressed |
| Carbamazepine | Carbamazepine | 81 | suppressed |
| Gemtesa | Vibegron | 81 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 80 | suppressed |
| Lactulose | Lactulose | 79 | 16 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 78 | 21 |
| Amantadine | Amantadine Hcl | 77 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 77 | 13 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 76 | suppressed |
| Lacosamide | Lacosamide | 74 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 74 | 14 |
| Tradjenta | Linagliptin | 74 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 72 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 70 | 27 |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 69 | suppressed |
| Bumetanide | Bumetanide | 68 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 59 | suppressed |
| Perphenazine | Perphenazine | 59 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 58 | suppressed |
| Brilinta | Ticagrelor | 57 | suppressed |
| Clonidine | Clonidine | 57 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 56 | suppressed |
| Bupropion Xl | Bupropion Hcl | 51 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 51 | 19 |
| Pregabalin | Pregabalin | 49 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 49 | 14 |
| Comfort Ez Pro Safety Pen Ndl | Pen Needle, Diabetic, Safety | 48 | 13 |
| Ezetimibe | Ezetimibe | 48 | suppressed |
| Calcitriol | Calcitriol | 47 | suppressed |
| Cilostazol | Cilostazol | 47 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 47 | suppressed |
| Ondansetron Odt | Ondansetron | 47 | 11 |
| Ssd | Silver Sulfadiazine | 46 | 19 |
| Cinacalcet Hcl | Cinacalcet Hcl | 45 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 45 | 42 |
| Bupropion Hcl | Bupropion Hcl | 44 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 43 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 40 | suppressed |
| Novolog Flexpen | Insulin Aspart | 40 | 14 |
| Baclofen | Baclofen | 39 | suppressed |
| Cephalexin | Cephalexin | 39 | 33 |
| Ranolazine Er | Ranolazine | 39 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 38 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 38 | suppressed |
| Glipizide | Glipizide | 38 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 38 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 35 | suppressed |
| Hydrocortisone | Hydrocortisone | 34 | suppressed |
| Imipramine Hcl | Imipramine Hcl | 34 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 34 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 32 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 32 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 32 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 31 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 30 | suppressed |
| Spironolactone | Spironolactone | 30 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 29 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 29 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 29 | suppressed |
| Allopurinol | Allopurinol | 28 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 28 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 28 | suppressed |
| Humalog | Insulin Lispro | 28 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 28 | suppressed |
| Ketoconazole | Ketoconazole | 28 | suppressed |
| Levemir Flexpen | Insulin Detemir | 28 | 11 |
| Loperamide | Loperamide Hcl | 28 | suppressed |
| Nystatin | Nystatin | 27 | 14 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 27 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 26 | suppressed |
| Prednisone | Prednisone | 26 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 26 | 20 |
| Admelog Solostar | Insulin Lispro | 25 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 25 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 25 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 25 | suppressed |
| Calcium Acetate | Calcium Acetate | 24 | suppressed |
| Gvoke Hypopen 2-Pack | Glucagon | 24 | suppressed |
| Valsartan | Valsartan | 24 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 24 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 23 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 23 | suppressed |
| Heparin Sodium | Heparin Sodium,porcine | 23 | suppressed |
| Ibuprofen | Ibuprofen | 23 | 14 |
| Lithium Carbonate | Lithium Carbonate | 23 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 22 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 22 | suppressed |
| Metolazone | Metolazone | 22 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 22 | suppressed |
| Chlorthalidone | Chlorthalidone | 21 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 21 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 20 | suppressed |
| Gemfibrozil | Gemfibrozil | 20 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 20 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 19 | suppressed |
| Haloperidol Lactate | Haloperidol Lactate | 19 | suppressed |
| Minoxidil | Minoxidil | 19 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 19 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 19 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 19 | suppressed |
| Clotrimazole | Clotrimazole | 18 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 18 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 18 | suppressed |
| Single Use Swab | Alcohol Antiseptic Pads | 17 | suppressed |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 16 | suppressed |
| Lansoprazole | Lansoprazole | 16 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 16 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 15 | 14 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 15 | suppressed |
| Sucralfate | Sucralfate | 15 | suppressed |
| Trifluoperazine Hcl | Trifluoperazine Hcl | 15 | suppressed |
| Budesonide | Budesonide | 14 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 14 | 11 |
| Clobetasol Propionate | Clobetasol Propionate | 14 | suppressed |
| Fluphenazine Decanoate | Fluphenazine Decanoate | 14 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 14 | suppressed |
| Insulin Glargine Solostar | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 14 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 14 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 14 | suppressed |
| Alprazolam | Alprazolam | 13 | suppressed |
| Celecoxib | Celecoxib | 13 | suppressed |
| Nitroglycerin | Nitroglycerin | 13 | suppressed |
| Nystop | Nystatin | 13 | suppressed |
| Scopolamine | Scopolamine | 13 | suppressed |
| Trospium Chloride | Trospium Chloride | 13 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 13 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 13 | suppressed |
| Acetazolamide Er | Acetazolamide | 12 | suppressed |
| Atomoxetine Hcl | Atomoxetine Hcl | 12 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 12 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 12 | suppressed |
| Cyclosporine | Cyclosporine | 12 | suppressed |
| Fluconazole | Fluconazole | 12 | suppressed |
| Jentadueto | Linagliptin/Metformin Hcl | 12 | suppressed |
| Lithium Carbonate Er | Lithium Carbonate | 12 | suppressed |
| Mupirocin | Mupirocin | 12 | suppressed |
| Tobramycin | Tobramycin | 12 | suppressed |
| Vascepa | Icosapent Ethyl | 12 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 11 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 11 | suppressed |
| Glatiramer Acetate | Glatiramer Acetate | 11 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 11 | suppressed |
| Mirabegron Er | Mirabegron | 11 | suppressed |
| Novolog | Insulin Aspart | 11 | suppressed |
| Primidone | Primidone | 11 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 11 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $663.76 · 9 records | Teva Pharmaceuticals USA, Inc. | AUSTEDO XR, COBENFY, DRIZALMA SPRINKLE, INGREZZA, KAPSPARGO | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with E.R. Squibb & Sons, L.L.C.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error